Literature DB >> 34694921

Association Between Time to First RNA-Negative Test Result Among People With Hepatitis C Virus Infection and Homelessness or Testing at a Correctional or Substance Use Treatment Facility, New York City.

Miranda S Moore1, Angelica Bocour1.   

Abstract

OBJECTIVE: Curative treatments for hepatitis C virus (HCV) infection are available, but access and barriers to treatment can delay initiation. We investigated the time to first negative RNA test result among people with HCV infection and examined differences by homeless status and whether people were tested at a correctional facility or substance use treatment facility.
METHODS: We used surveillance data to identify New York City residents first reported with HCV infection during January 1, 2015-December 31, 2018, with ≥1 positive RNA test result during January 1, 2015-November 1, 2019. We used Kaplan-Meier survival analysis to determine the time from the first positive RNA test result to the first negative RNA test result, with right-censoring at date of death or November 1, 2019. We determined substance use treatment, incarceration, or homelessness by ordering facility name and address or from patient residential address.
RESULTS: Of 13 952 people with an HCV RNA-positive test result first reported during 2015-2018, 6947 (49.8%) subsequently received an RNA-negative test result. Overall, 25% received an RNA-negative test result within 208 (95% CI, 200-216) days and 50% within 902 (95% CI, 841-966) days. Homelessness, incarceration, or substance use treatment was indicated for 4304 (30.9%) people, among whom 25% received an RNA-negative test result within 469 (95% CI, 427-520) days and <50% received an RNA-negative test result during the study period.
CONCLUSIONS: Efforts to connect people to treatment should occur soon after diagnosis, especially for people who could benefit from hepatitis C care coordination.

Entities:  

Keywords:  RNA-negative timing; hepatitis C virus; homelessness; incarceration; substance use treatment

Mesh:

Substances:

Year:  2021        PMID: 34694921      PMCID: PMC9574298          DOI: 10.1177/00333549211049263

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   3.117


  44 in total

Review 1.  Benefits of curing hepatitis C infection.

Authors:  Rui T Marinho; Sofia Vitor; Jose Velosa
Journal:  J Gastrointestin Liver Dis       Date:  2014-03       Impact factor: 2.008

2.  A costing analysis of a state-wide, nurse-led hepatitis C treatment model in prison.

Authors:  Anna Palmer; Timothy Papaluca; Mark Stoové; Rebecca Winter; Alisa Pedrana; Margaret Hellard; David Wilson; Alexander Thompson; Nick Scott
Journal:  Int J Drug Policy       Date:  2021-03-18

3.  Restrictions of Hepatitis C Treatment for Substance-Using Medicaid Patients: Cost Versus Ethics.

Authors:  Joshua M Liao; Michael A Fischer
Journal:  Am J Public Health       Date:  2017-04-20       Impact factor: 9.308

4.  Increased diagnosis and treatment of hepatitis C in prison by universal offer of testing and use of telemedicine.

Authors:  Sarah Morey; Abi Hamoodi; Dee Jones; Tina Young; Craig Thompson; Julie Dhuny; Emma Buchanan; Carolyn Miller; Margaret Hewett; Manoj Valappil; Ewan Hunter; Stuart McPherson
Journal:  J Viral Hepat       Date:  2018-11-28       Impact factor: 3.728

Review 5.  Homeless health care: meeting the challenges of providing primary care.

Authors:  Andrew Davies; Lisa J Wood
Journal:  Med J Aust       Date:  2018-08-03       Impact factor: 7.738

6.  Concurrent group treatment for hepatitis C: implementation and outcomes in a methadone maintenance treatment program.

Authors:  Melissa R Stein; Irene J Soloway; Karen S Jefferson; Robert J Roose; Julia H Arnsten; Alain H Litwin
Journal:  J Subst Abuse Treat       Date:  2012-10-02

7.  From Care to Cure: Demonstrating a Model of Clinical Patient Navigation for Hepatitis C Care and Treatment in High-Need Patients.

Authors:  Mary M Ford; Nirah Johnson; Payal Desai; Eric Rude; Fabienne Laraque
Journal:  Clin Infect Dis       Date:  2016-12-10       Impact factor: 9.079

8.  A unique model for treating chronic hepatitis C in patients with psychiatric disorders, substance abuse, and/or housing instability.

Authors:  Cheryl J Ho; Charles Preston; Kim Fredericks; Sara L Doorley; Richard J Kramer; Lawrence Kwan; Ahmad Kamal
Journal:  J Addict Med       Date:  2013 Sep-Oct       Impact factor: 3.702

9.  HCV screening in a cohort of HIV infected and uninfected homeless and marginally housed women in San Francisco, California.

Authors:  Kimberly Page; Michelle Yu; Jennifer Cohen; Jennifer Evans; Martha Shumway; Elise D Riley
Journal:  BMC Public Health       Date:  2017-02-07       Impact factor: 3.295

10.  Feasibility of Treating Hepatitis C in a Transient Jail Population.

Authors:  Ross MacDonald; Matthew J Akiyama; Aimee Kopolow; Zachary Rosner; Wendy McGahee; Rodrigue Joseph; Mohamed Jaffer; Homer Venters
Journal:  Open Forum Infect Dis       Date:  2017-07-07       Impact factor: 3.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.